Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PH vs GSK✓SelectedUSD · GSKPH vs GSK performance historyLatest closeAs of-0.22%11/18
Stock and ETF performance explorer

PH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+194.2%
GSK return
+42.7%
Excess return
+151.5%
Maximum drawdown
-28.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.2%-1.3%+1.1%0.0%
7D-5.4%-3.1%-2.2%-4.8%
30D-4.7%-0.9%-3.8%-4.7%
3M-11.4%-4.2%-7.3%-10.9%
6M+7.5%-1.6%+9.1%+7.3%
YTD+5.4%+2.6%+2.8%+4.4%
1Y+13.4%+6.2%+7.1%+11.5%
3Y+118.6%+55.0%+63.6%+95.0%
5Y+194.2%+42.8%+151.4%+141.7%
All+194.2%+42.7%+151.5%+141.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling